Mifepristone
Cat.No:IM0320 Solarbio
CAS:84371-65-3
Molecular Formula:C29H35NO2
Molecular Weight:429.59
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:Light yellow to yellow Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Endocrinology & Hormones > MifepristoneCAS:84371-65-3
Molecular Formula:C29H35NO2
Molecular Weight:429.59
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:Light yellow to yellow Solid
Qty:
Size:
| CAS | 84371-65-3 |
| Name | Mifepristone |
| Molecular Formula | C29H35NO2 |
| Molecular Weight | 429.59 |
| Solubility | Soluble in DMSO |
| Purity | HPLC≥98% |
| Appearance | Light yellow to yellow Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| EC | EINECS 617-559-7 |
| MDL | MFCD00867226 |
| SMILES | C[C@@]12[C@@](C#CC)(O)CC[C@@]1([H])[C@]3([H])CCC4=CC(CCC4=C3[C@@H](C5=CC=C(N(C)C)C=C5)C2)=O |
| InChIKey | VKHAHZOOUSRJNA-GCNJZUOMSA-N |
| InChI | InChI=1S/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1 |
| PubChem CID | 55245 |
| Target Point | Progesterone Receptor; Glucocorticoid Receptor |
| Passage | Endocrinology & Hormones |
| Background | Mifepristone is a progesterone receptor (PR) and glucocorticoid receptor (GR) antagonist. |
| Biological Activity | Mifepristone是黄体酮受体 (PR) 和糖皮质激素受体 (GR) 拮抗剂,体外实验中的 IC50 值分别为0.2 nM 和2.6 nM。[1-3] |
| Data Literature Source | [1]. Jiang W,et al. New progesterone receptor antagonists: phosphorus-containing 11beta-aryl-substituted steroids. Bioorg Med Chem. 2006 Oct 1;14(19):6726-32. [2]. Jurado R,et al. Cisplatin cytotoxicity is increased by mifepristone in cervical carcinoma: an in vitro and in vivo study. Oncol Rep. 2009 Nov;22(5):1237-45. [3]. Sharrett-Field L,et al. Mifepristone Pretreatment Reduces Ethanol Withdrawal Severity In Vivo. Alcohol Clin Exp Res. 2013 Aug;37(8):1417-23 |
| Unit | Bottle |
| Specification | 50mg 10mM*1mL in DMSO 100mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Mitigating placental injuries through up-regulating DAF in experimental APS mice: new mechanism of progesterone.
Click to check >>Author:Zhang Y, Jin S.
IF:3.7300
Publish_to:Clin Exp Immunol.
PMID:31091357
Manual Download